Company Filing History:
Years Active: 2018
Title: The Innovations of George Trendelenburg
Introduction
George Trendelenburg is a notable inventor based in Goettingen, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of neuroautoimmune diseases. His innovative work has led to the development of a patented method that enhances the diagnosis and treatment of these complex conditions.
Latest Patents
George Trendelenburg holds a patent for the "Diagnosis of a neuroautoimmune disease comprising measuring autoantibodies to flotillin1 and/or flotillin2." This patent outlines a method for diagnosing a disease by detecting an autoantibody that binds to flotillin1 and/or flotillin2 in a sample. It also includes a polypeptide comprising flotillin1 and/or flotillin2 or a variant thereof, which may be immobilized. Furthermore, the patent describes a method of treating a disease by applying to a subject the polypeptide that binds to an autoantibody, an autoantibody binding to flotillin1 and/or flotillin2, and a method for isolating the autoantibody. Additionally, it covers a pharmaceutical composition, a medical device, and a test kit comprising the polypeptide. A method for detecting the presence of an autoantibody is also provided.
Career Highlights
George Trendelenburg is associated with Euroimmun Medizinische Labordiagnostika AG, a company known for its advancements in medical laboratory diagnostics. His work at Euroimmun has allowed him to focus on innovative solutions that improve patient outcomes in the field of autoimmune diseases.
Collaborations
Throughout his career, George has collaborated with notable colleagues such as Winfried Stoecker and Lars Komorowski. These collaborations have contributed to the advancement of research and development in medical diagnostics.
Conclusion
George Trendelenburg's contributions to the field of medical diagnostics through his innovative patent demonstrate his commitment to improving healthcare. His work continues to influence the diagnosis and treatment of neuroautoimmune diseases, showcasing the importance of innovation in medicine.